Cargando…

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients

BACKGROUND: XRCC2, a homologous recombination-related gene, has been reported to be associated with a variety of cancers. However, its role in glioma has not been reported. This study aimed to find out the role of XRCC2 in glioma and reveal in which glioma-specific biological processes is XRCC2 invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhendong, Zhang, Wang, Cheng, Xingbo, Wang, Hongbo, Bian, Lu, Wang, Jialin, Han, Zhibin, Wang, Yanbiao, Lian, Xiaoyu, Liu, Binfeng, Ren, Zhishuai, Zhang, Bo, Jiang, Zhenfeng, Lin, Zhiguo, Gao, Yanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164800/ https://www.ncbi.nlm.nih.gov/pubmed/34051735 http://dx.doi.org/10.1186/s10020-021-00316-0

Ejemplares similares

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes
por: Yu, Zhenghong, et al.
Publicado: (2022)

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
por: Zhu, Qingyun, et al.
Publicado: (2023)

Cemented versus uncemented hemiarthroplasty for elderly patients with displaced fracture of the femoral neck: A PRISMA-compliant meta-analysis of randomized controlled trial
por: Liu, Binfeng, et al.
Publicado: (2020)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
por: Gu, Zhuoyu, et al.
Publicado: (2018)

Prognostic significance of HSF2BP in lung adenocarcinoma
por: Huang, Zhendong, et al.
Publicado: (2021)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

Exploring the Key Genes and Pathways in the Formation of Corneal Scar Using Bioinformatics Analysis
por: Liu, Binfeng, et al.
Publicado: (2020)

TGIF1 overexpression promotes glioma progression and worsens patient prognosis
por: Wang, Baoya, et al.
Publicado: (2022)

Expression and clinical significance of UBE2V1 in cervical cancer
por: Ren, Zhishuai, et al.
Publicado: (2021)

Biomechanical Comparison of a New Memory Compression Alloy Plate versus Traditional Titanium Plate for Anterior Cervical Discectomy and Fusion: A Finite Element Analysis
por: Liu, Jiantao, et al.
Publicado: (2020)

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth
por: Wang, Yiwei, et al.
Publicado: (2018)

Biomechanical properties of a novel nonfusion artificial vertebral body for anterior lumbar vertebra resection and internal fixation
por: Liu, Jiantao, et al.
Publicado: (2021)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015)

Association between XRCC1 and XRCC3 Polymorphisms with Lung Cancer Risk: A Meta-Analysis from Case-Control Studies
por: Huang, Guohua, et al.
Publicado: (2013)

Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas
por: Yu, Shoukai
Publicado: (2022)

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas
por: Guan, Xiudong, et al.
Publicado: (2018)

Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis
por: Wu, Changwu, et al.
Publicado: (2019)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

FOXL1 overexpression is associated with poor outcome in patients with glioma
por: Chen, Ainian, et al.
Publicado: (2019)

XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls
por: Zhang, Liang, et al.
Publicado: (2013)

Role of Paralogue of XRCC4 and XLF in DNA Damage Repair and Cancer Development
por: Tang, Jialin, et al.
Publicado: (2022)

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma
por: Liu, Yi, et al.
Publicado: (2021)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h7hpk4pfcck50vjrmgd6mi5flk